The inconsistent Europe 2020 and research strategy

That is the main conclusion of the House of Lords Internal Market, Infrastructure and Employment EU Sub-Committee in its report published today, following its short inquiry into the effectiveness of EU research and innovation proposals. Although the Committee recognises the work that the Government is already doing in introducing a better regulation agenda with the EU Commission, it is vital that, in order for British SMEs to expand and grow, progress must continue to be made.

ByNick Chiu:Gilead Sciences, Inc. (GILD), with a market cap of $68.16B, is a research-based biopharmaceutical company, which develops and markets therapies to treat life-threatening infectious diseases with the core portfolio focused on HIV, liver diseases, such as hepatitis B and C, and cardiovascular/metabolic and respiratory conditions. GILD was down 1.16% and closed at $44.98 on March 25, 2013.

House Majority Leader Eric Cantor wants to offer the social scientists a NSF budget of $0.  He is a smart man who argues that there is an opportunity cost to giving the "wacky" social scientists $250 million a year.  He argues that the scarce $ could be handed to "real scientists".   He writes:

Fascinating read in the March 2011 issue of Wired magazine documenting an increasing trend among U.S. small businesses: They seem to be bringing manufacturing work that had been outsourced to China back stateside (see Small Businesses Buck Trend, ht Jon). According to Wired:

Charles Wyplosz, 31 March 2010Should Germany increase its spending on other Eurozone exports to help ease the region’s imbalances? This column argues that Europe is not the world and telling Germany to reduce its current account surplus is unwarranted. With an ageing population, Germany would be well-advised to save for a couple of decades – as would the rest of Europe.Full Article: Germany, current accounts and competitiveness